¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"dense enhancement"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dense
    Á¶¹Ð-, Ä¡¹Ð-, ÁøÇÑ-
  • dense body
    Ä¡¹Ð¼Òü
  • dense core vesicle
    Ä¡¹Ð¼ÒÆ÷
  • dense deposit disease
    °í¹ÐµµÄ§Âøº´
  • dense fiber
    Ä¡¹Ð¼¶À¯
  • dense glomus
    Ä¡¹ÐÅ丮
  • major dense line
    ūġ¹Ð¼±
  • acoustic enhancement
    ¼Ò¸®Áõ°­, À½ÇâÁõ°­
  • contrast enhancement
    Á¶¿µÁõ°­
  • contrast enhancement ratio
    Á¶¿µÁõ°­ºñ
  • contrast enhancement scan
    Á¶¿µÁõ°­½ºÄµ
  • edge enhancement
    °¡ÀåÀÚ¸®Áõ°­
  • enhancement
    1. ÃËÁø 2. Áõ°­ 3. °­È­
  • enhancement medium
    Áõ°­¹èÁö
  • oxygen enhancement ratio
    »ê¼ÒÈ¿°úÁõ°­·ü, »ê¼ÒÁõ°­ºñ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • enhancement
    Áõ°­, ÁõÁø
  • dense core vesicle
    Ä¡¹Ð¼ÒÆ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dense enhancement
    °­ÇÑÁ¶¿µÁõ°­
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dense body
    Ä¡¹Ð¼Òü
  • dense
    Á¶¹Ð-, Ä¡¹Ð-, ÁøÇÑ-
  • dense fiber
    Ä¡¹Ð¼¶À¯
  • dense glomus
    Ä¡¹ÐÅ丮
  • dense core vesicle
    Ä¡¹Ð¼ÒÆ÷
  • dense deposit disease
    °í¹ÐµµÄ§Âøº´
  • major dense line
    ūġ¹Ð¼±
  • acoustic enhancement
    ¼Ò¸®Áõ°­, À½ÇâÁõ°­
  • contrast enhancement
    Á¶¿µÁõ°­
  • contrast enhancement ratio
    Á¶¿µÁõ°­ºñ
  • contrast enhancement scan
    Á¶¿µÁõ°­½ºÄµ
  • enhancement
    Áõ°­, ÁõÁø
  • edge enhancement
    °¡ÀåÀÚ¸®Áõ°­
  • enhancement medium
    Áõ°­¹èÁö
  • immunologic enhancement
    ¸é¿ª±âÇÇÀ¯µµ, ¸é¿ªÃËÁø
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • OER [=oxygen enhancement ratio]
    »ê¼Ò°­È­À²
  • acoustic enhancement
    À½Çâ Áõ°­
  • immune enhancement
    ¸é¿ªÇÐÀûÃËÁø (Á¾¾çÁõ½ÄÀÇ)
  • immunological enhancement
    ¸é¿ªÁõ°­.
  • immunological enhancement
    ¸é¿ªÁõ°­.
  • postanodal enhancement
    ¾ç±ØÈÄÁõ°­.
  • postanodal enhancement
    ¾ç±ØÈÄÁõ°­(åÕпý­ñòË­)
  • posterior echo enhancement
    ÈÄ¹æ ¿¡ÄÚ Áõ°­, ÈÄ¹æ ¸Þ¾Æ¸®Áõ°­
  • posterior echo enhancement
    ÈĹæ (ý­Û°) ¿¡ÄÚ Áõ°­ (ñòË­), ÈĹæ (ý­Û°) ¸Þ¾Æ¸® ?
  • rapid acquisition with relaxation enhancement (RARE)
    ±Þ¼Ó ȹµæ ÀÌ¿Ï Áõ°­
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dense enhancement
    °­ÇÑ Á¶¿µÁõ°­
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dense
    Á¶¹ÐÇÑ, Ä¡¹ÐÇÑ, ÁøÇÑ
  • dense bodies
    Ä¡¹Ð¼Òü(öÆÚËá³ô÷)
  • dense body
    ¹ÐÁýü(ÚËó¢ô÷)
  • dense body
    Ä¡¹Ð¼Òü
  • dense collagenous connective tissue
    Ä¡¹Ð¾Æ±³°áÇÕÁ¶Á÷
  • dense connective tissue
    Ä¡¹Ð°áÇÕÁ¶Á÷(öÆÚËÌ¿ùêðÚòÄ).
  • dense core vesicle
    Ä¡¹Ð¼ÒÆ÷
  • dense fiber
    Ä¡¹Ð¼¶À¯
  • dense glomus
    Ä¡¹ÐÅ丮
  • dense plaque
    Á¶¹ÐÆÇ
  • dense-deposit disease
    °í¹Ðµµ Ä§Âøº´(ÍÔÚËÓøöØó·Ü»)
  • electron dense bodies
    ÀüÀڹеµ¼Òü
  • major dense line
    ūġ¹Ð¼±, ´ëÄ¡¹Ð¼±(ÓÞöÆÚËàÊ).
  • acoustic enhancement
    À½Çâ Áõ°­
  • contrast enhancement
    Á¶¿µ Áõ°­
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Dense collagenous connective tissue
    Ä¡¹Ð¾Æ±³°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] Ä¡¹Ð°áÇÕÁ¶Á÷
  • Dense fiber
    Ä¡¹Ð¼¶À¯
    [¿¾ ¿ë¾î] Á¶¹Ð¼¶À¯
  • Dense fiber
    Ä¡¹Ð¼¶À¯
    [¿¾ ¿ë¾î] Ä¡¹Ð¼¶À¯
  • Dense core vesicle
    Ä¡¹Ð¼ÒÆ÷
    [¿¾ ¿ë¾î] Ä¡¹Ð¼ÒÆ÷
  • Dense body
    Ä¡¹Ð¼Òü
    [¿¾ ¿ë¾î] Ä¡¹Ð¼Òü
  • Dense glomus
    Ä¡¹ÐÅ丮
    [¿¾ ¿ë¾î] Ä¡¹Ð»ç±¸
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • enhancement
    Áõ°­(ñòË­)
  • enhancement effect
    Áõ°­ È¿°ú (ñòË­üùÍý)
  • fluorescence enhancement
    Çü±¤ Áõ°­(û«ÎÃñòË­)
  • immunological enhancement
    ¸é¿ª Áõ°­(Øóæ¹ñòË­)
  • migration enhancement factor
    À̵¿Ç×Áø ÀÎÀÚ(ì¹ÔÑùñòäì×í­)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dense enhancement
    °­ÇÑ Á¶¿µÁõ°­
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dense
    Á¶¹ÐÇÑ, £Àº, Ä¡¹ÐÇÑ
  • acoustic enhancement
    À½ÇâÁõ°­
  • CE [=contrast enhancement]
    Á¶¿µÁõ°­
  • contrast enhancement [=CE]
    Á¶¿µÁõ°­
  • contrast enhancement ratio
    Á¶¿µÁõ°­ºñ
  • contrast enhancement scan
    Á¶¿µÁõ°­½ºÄµ
  • edge enhancement
    º¯¿¬Áõ°­
  • enhancement
    Áõ°­
  • flow related enhancement
    À¯µ¿°ü·ÃÁõ°­
  • gradient echo technique magnetic susceptibility proton relaxation enhancement
    °æ»ç¿¡ÄÚ¹ý±âÈ­À²¼ºÀÚÀÌ¿ÏÁõ°­
  • inflow enhancement
    À¯ÀÔÁõ°­
  • minimal enhancement
    ¹Ì¹ÌÇÑÁ¶¿µÁõ°­, °æµµÀÇÁ¶¿µÁõ°­
  • paradoxical enhancement
    ¿ª¼³ÀûÁ¶¿µÁõ°­
  • paramagnetic proton relaxation enhancement
    »óÀÚ¼º¾çÀÚÀÌ¿ÏÁõ°­
  • peripheral linear enhancement
    ¸»Ãʼ±ÇüÁ¶¿µÁõ°­
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DB data base; date of birth; deep breath; dense body; dextran blue; diabetes, diabetic; diagonal band; ...
DCS decompression sickness; dense canalicular system; diffuse cortical sclerosis; dorsal column stimulat...
DDD AV universal [pacemaker]; defined daily dose; degenerative disc disease; dehydroxydinaphthyl disulfi...
DFECT dense fibroelastic connective tissue
DIDD dense intramembranous deposit disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
dcv Dense core-vesicles
DNAPL dense non-aqueous phase liquid
EDD Electron dense deposits
LDCV Large dense core vesicles
LDV Large dense core vesicles
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dense body
    ³ó¿°Ã¼
    °ñ°Ý±ÙÀÇ ±ÙÁú³»¿¡ ÀÖ´Â ³óµµ°¡ £Àº ÀÛÀº ºÎÀ§·Î¼­ ±Ù¿ø¼¶À¯°¡ ºÎÂøµÇ¾î ÀÖ´Ù.
  • dense connective tissue
    Ä¡¹Ð °áÇÕÁ¶Á÷
    ±³¿ø¼¶À¯°¡ dzºÎÇÏ°Ô °¡µæ Â÷ ÀÖ´Â °áÇÕÁ¶Á÷.
  • dense fibrous connective tissue
    Ä¡¹Ð ¼¶À¯¼º °áÇÕ Á¶Á÷
  • electro-dense
    ÀüÀÚ ¹ÐµµÀÇ, ÀüÀÚ ºÒÅõ°ú ¹ÐµµÀÇ
    ÀüÀÚÇö¹Ì°æ¿¡¼­ ÀüÀÚÀÇ Åõ°ú¸¦ ¸·À» ¼ö ÀÖ´Â µÎ²² ¶Ç´Â ¹Ðµµ´Â °®´Â.
  • acoustic enhancement
    À½Çâ Áõ°­
  • contrast enhancement
    Á¶¿µ Áõ°­
  • contrast enhancement scan
    Á¶¿µ Áõ°­ ½ºÄµ
  • edge enhancement
    °è¸é Áõ°­
  • immunological enhancement
    ¸é¿ª Áõ°­ Çö»ó, ¸é¿ª Áõ°­
    ¸é¿ª ¹ÝÀÀÀÇ ¼öÁØÀ» Áõ´ë½ÃŰ´Â ¿©·¯ °¡Áö ƯÀÌÀû ¶Ç´Â ºñƯÀÌÀû »óȲ.
  • minimal enhancement
    ¹Ì¹ÌÇÑ Á¶¿µ Áõ°­, °æµµÀÇ Á¶¿µ Áõ°­
  • paradoxical enhancement
    ¿ª¼³Àû Á¶¿µ Áõ°­
  • paramagnetic proton relaxation enhancement
    »óÀÚ¼º ¾çÀÚ ÀÌ¿Ï Áõ°­
  • peripheral linear enhancement
    ¸»ÃÊ ¼±Çü Á¶¿µ Áõ°­
  • peripheral rim enhancement
    Å׵θ® Á¶¿µ Áõ°­
  • rim enhancement
    Å׵θ® Á¶¿µ Áõ°­
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
pericanicular dense bodies <cell biology> Electron dense membrane bounded cytoplasmic organelles found near the canaliculi in liver cells: lysosomes.
(18 Nov 1997)
subplasmalemmal dense zone An electron-dense, 10-15 nm thick layer of highly cross-linked protein on the cytoplasmic surface of the cell membrane of epidermal corneocytes; it is highly resistant to proteolytic agents.
Synonym: subplasmalemmal dense zone.
(05 Mar 2000)
dense bodies <cell biology> Areas of electron density associated with the thin filaments in smooth muscle cells. Some are associated with the plasma membrane, others are cytoplasmic.
(12 Jan 1998)
dense-deposit disease See: membranoproliferative glomerulonephritis.
(05 Mar 2000)
dense liver <radiology> Haemochromatosis, haemosiderosis, Wilson disease, Thorotrast, amiodarone, gold (for RA)
(12 Dec 1998)
dense metaphyseal bands <radiology> Normal variant, stress lines, heavy metal poisoning, treated rickets, scurvy, hypervitaminosis D
(12 Dec 1998)
dense spleen <radiology> Sickle cell disease, haemochromatosis, Thorotrast
(12 Dec 1998)
large, dense breast lesions <radiology> Carcinoma, sarcoma, cystosarcoma phylloides, cyst, abscess, lymph nodes (lymphoma, leukaemia, metastasis)
(12 Dec 1998)
acoustic enhancement A manifestation of increased acoustic signal amplitude returning from regions beyond an object which causes little or no attenuation of the sound beam.
Compare: acoustic shadow.
(05 Mar 2000)
antibody-dependent enhancement Enhancement of viral infectivity caused by non-neutralizing antibodies. There are at least two mechanisms known to account for this: mediation by fc receptors (receptors, fc) or by complement receptors (receptors, complement). Either the virus is complexed with antiviral IgG and binds to fc receptors, or virus is coated with antiviral IgM and binds to complement receptors.
(12 Dec 1998)
radiographic image enhancement Improvement in the quality of an X-ray image by use of an intensifying screen, tube, or filter and by optimum exposure techniques. Digital processing methods are often employed.
(12 Dec 1998)
graft enhancement, immunologic The induction of prolonged survival and growth of allografts of either tumours or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunised donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity.
(12 Dec 1998)
ring enhancement In computed tomography, when a bright circle appears on an image made after injection of contrast medium, characteristic of localization of the contrast in the wall of an abscess.
(05 Mar 2000)
contrast enhancement The intravenous administration of water-soluble iodinated contrast material, which increases the CT number of the vascular pool, as well as some lesions (particularly in the brain), due to abnormal leakage into the interstitium; the property of showing increased radiopacity from concentration of contrast medium.
(05 Mar 2000)
image enhancement Improvement of the quality of a picture by various techniques, including computer processing, digital filtering, echocardiographic techniques, light and ultrastructural microscopy, fluorescence spectrometry and microscopy, scintigraphy, and in vitro image processing at the molecular level.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • enhancement
    (°¡°Ý,¸Å·Â,°¡Ä¡ µîÀÇ)»ó½Â;µî±Í;Çâ»ó;Áõ´ë
  • revenue enhancement
    ¼¼ÀÔ Áõ°¡(Áõ¼¼¶ó´Â ¸» ´ë½Å ¾²´Â Ç¥Çö)
  • dense
    ¹ÐÁýÇÑ
  • dense
    Á¶¹ÐÇÑ;£Àº;¿ìµÐÇÑ
  • dense pack
    (¹Ì)(Àü·« ¹Ì»çÀÏÀÇ)¹ÐÁý ¹èÄ¡(¹æ½Ä)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á